▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Durect (NASDAQ: DRRX)

Some price data may be temporarily unavailable.

Durect Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
DRRX	+27.33%	-88.06%	-34.63%	-99%
S&P	+16.07%	+97.84%	+14.62%	+360%

Durect Company Info

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

News & Analysis

Featured Article

Durect Posts Narrower Loss in Fiscal Q2

Motley Fool Markets Team | Aug 12, 2025

Featured Article

Is It Too Late to Buy These 3 Pharmaceutical Stocks?

Relmada Therapeutics, Neoleukin Therapeutics, and Durect were among the fastest-rising pharmaceutical stocks over the past year.

James Halley | Jul 7, 2020

Here's Why Shares of Durect Jumped Higher Today

Brian Orelli, PhD | May 12, 2020

The biotech becomes a COVID-19 play and benefits from a competitor's failure.

These Were the 10 Best Stocks of 2019

Taylor Carmichael | Jan 6, 2020

Seven biotechs led the way.

Here's Why Shares of DURECT Plummeted Today

Brian Orelli, PhD | Jan 2, 2020

The biotech's midstage study of DUR-928 failed, but the drug isn't dead yet.

Here's Why DURECT Jumped Higher Today

Brian Orelli, PhD | Dec 31, 2019

Investors jump in ahead of a binary event.

2 Biotech Stocks That Could Double Your Money

Cory Renauer | Sep 7, 2019

Hardly anyone's heard of either of these drugmakers, but some analysts think they could be top performers.

Why Durect Stock Is Up Today

Brian Feroldi | Sep 6, 2019

Investors bid up the share price after the company received some bullish praise from a Wall Street pro.

Valuation

Earnings Transcripts

Durect Corp (DRRX) Q3 2020 Earnings Call Transcript

DRRX earnings call for the period ending September 30, 2020.

Motley Fool Transcribers | Nov 2, 2020

Durect Corp (DRRX) Q2 2020 Earnings Call Transcript

DRRX earnings call for the period ending June 30, 2020.

Motley Fool Transcribers | Aug 4, 2020

Durect Corp (DRRX) Q1 2020 Earnings Call Transcript

DRRX earnings call for the period ending March 31, 2020.

Motley Fool Transcribers | May 12, 2020

Durect Corp (DRRX) Q4 2019 Earnings Call Transcript

DRRX earnings call for the period ending December 31, 2019.

Motley Fool Transcribers | Mar 4, 2020

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services